2
Clinical Trials associated with Zoster vaccine, Live(Changchun Changsheng Life Sciences) / Active, not recruitingPhase 3 在中国40岁及以上人群中评价带状疱疹减毒活疫苗保护效力的多中心、随机、双盲、安慰剂对照设计的III期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the protective efficacy of live attenuated herpes zoster vaccine in Chinese people aged 40 years and above
主要目的:评价接种疫苗30天后预防带状疱疹的保护效力。 次要目的: 1.评价接种疫苗后预防带状疱疹和预防/减轻PHN的保护效力; 2.评价接种疫苗30天后预防/减轻PHN和预防/减轻重度带状疱疹相关急性期疼痛(ZBPI评分≥3)的保护效力; 3.评价接种疫苗后的安全性、免疫原性和免疫持久性。
[Translation] Primary objective: To evaluate the protective efficacy of the vaccine against herpes zoster 30 days after vaccination. Secondary objectives: 1. To evaluate the protective efficacy of the vaccine against herpes zoster and PHN; 2. To evaluate the protective efficacy of the vaccine against PHN and severe herpes zoster-related acute pain (ZBPI score ≥ 3) 30 days after vaccination; 3. To evaluate the safety, immunogenicity and immune persistence after vaccination.
评价不同剂量带状疱疹减毒活疫苗安全性和初步免疫原性的Ⅰ、Ⅱ期临床试验
[Translation] Phase I and II clinical trials to evaluate the safety and preliminary immunogenicity of different doses of herpes zoster live attenuated vaccine
评价不同剂量带状疱疹减毒活疫苗接种于≥40岁人群的安全性和免疫原性。
[Translation] To evaluate the safety and immunogenicity of different doses of live attenuated herpes zoster vaccine in people aged ≥40 years.
100 Clinical Results associated with Zoster vaccine, Live(Changchun Changsheng Life Sciences)
100 Translational Medicine associated with Zoster vaccine, Live(Changchun Changsheng Life Sciences)
100 Patents (Medical) associated with Zoster vaccine, Live(Changchun Changsheng Life Sciences)
100 Deals associated with Zoster vaccine, Live(Changchun Changsheng Life Sciences)